European Union investigators are widening a probe of the pharmaceutical industry as they look into whether drug companies have used unfair tactics to block competition and prop up prices.
In recent weeks, investigators have sent questionnaires to drug wholesalers and trading firms, asking them about pharmaceutical companies' distribution methods and other practices.
